CMC Biologics is leading the industry among CDMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, we provide fully integrated biopharmaceutical development and manufacturing solutions to clients globally; with proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
Our wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing. Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. We provide fully segregated microbial fermentation and mammalian cell culture suites and offer both fed-batch and perfusion production processes.